AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Cardinal Health reported Q4 non-GAAP operating earnings of $719 million, a 19% increase, and non-GAAP EPS of $2.08. FY2025 revenue was $222.6 billion, a 2% decrease, but non-GAAP operating earnings rose 15% to $2.8 billion. The company raised FY2026 non-GAAP EPS guidance to $9.30-$9.50, a 13-15% increase, and plans to repurchase $750 million worth of shares.
Cardinal Health (NYSE: CAH) reported its fourth quarter (Q4) and fiscal year 2025 (FY25) results, showing a relatively flat revenue of $60.2 billion for the quarter and a 2% decrease in FY25 revenue to $222.6 billion compared to the previous year. Despite the revenue changes, the company's non-GAAP operating earnings increased significantly. Q4 non-GAAP operating earnings were $719 million, a 19% increase, while non-GAAP EPS was $2.08, a 13% increase. For the full year, non-GAAP operating earnings rose 15% to $2.8 billion, with non-GAAP EPS increasing 9% to $8.24 [1].
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet